webinar
Oct. 27-28, 2025, Boston, MA, USA - Booth 114.
Read More

Fmoc-GGFG-Glycolic acid

  CAS No.: 2264011-98-3   Cat No.: BADC-01480 4.5  

Fmoc-GGFG-Glycolic acid is a peptide ADC linker intermediate incorporating Gly-Gly-Phe-Gly sequence with glycolic acid for enzyme-triggered cleavable linkage, enabling controlled payload release in antibody-drug conjugates. Keywords: ADC linker, peptide linker, cleavable linker, enzyme-sensitive, controlled release.

Fmoc-GGFG-Glycolic acid

Structure of 2264011-98-3

Quality
Assurance

Worldwide
Delivery

24/7 Customer
Support
Category
ADC Linker
Molecular Formula
C33H35N5O9
Molecular Weight
645.66

* For research and manufacturing use only. We do not sell to patients.

Size Price Stock Quantity
-- $-- In stock

Looking for different specifications? Click to request a custom quote!

Capabilities & Facilities

Popular Publications Citing BOC Sciences Products
Synonyms
Fmoc-Gly-Gly-L-Phe-N-[(carboxymethoxy)methyl]Glycinamide; (S)-11-Benzyl-1-(9H-fluoren-9-yl)-3,6,9,12,15-pentaoxo-2,18-dioxa-4,7,10,13,16-pentaazaicosan-20-oic acid
IUPAC Name
2-[[[2-[[(2S)-2-[[2-[[2-(9H-fluoren-9-ylmethoxycarbonylamino)acetyl]amino]acetyl]amino]-3-phenylpropanoyl]amino]acetyl]amino]methoxy]acetic acid
Canonical SMILES
C1=CC=C(C=C1)CC(C(=O)NCC(=O)NCOCC(=O)O)NC(=O)CNC(=O)CNC(=O)OCC2C3=CC=CC=C3C4=CC=CC=C24
InChI
InChI=1S/C33H35N5O9/c39-28(16-36-33(45)47-18-26-24-12-6-4-10-22(24)23-11-5-7-13-25(23)26)34-17-30(41)38-27(14-21-8-2-1-3-9-21)32(44)35-15-29(40)37-20-46-19-31(42)43/h1-13,26-27H,14-20H2,(H,34,39)(H,35,44)(H,36,45)(H,37,40)(H,38,41)(H,42,43)/t27-/m0/s1
InChIKey
JOZGCSZISBFCOO-MHZLTWQESA-N
Appearance
White Solid

Fmoc-GGFG-Glycolic acid, a renowned peptide conjugate, finds widespread application in peptide synthesis and bioconjugation. Discover four key applications of Fmoc-GGFG-Glycolic acid:

Peptide Synthesis: Serving as a versatile building block in solid-phase peptide synthesis, Fmoc-GGFG-Glycolic acid enables the construction of intricate peptide structures. With its Fmoc protection strategy, it facilitates the methodical assembly of peptides by thwarting premature reactions, empowering researchers to synthesize peptides for diverse therapeutic, diagnostic, and research purposes.

Drug Delivery Systems: Fmoc-GGFG-Glycolic acid contributes to the design of innovative drug delivery systems encompassing peptide-drug conjugates and nanoparticles. By integrating glycolic acid, this compound enhances the solubility and stability of peptide-based therapeutics, thereby improving drug bioavailability and controlled release. Its utility in targeted drug delivery applications underscores its significance in pharmaceutical advancements.

Biomaterials Development: At the forefront of biomaterials innovation, Fmoc-GGFG-Glycolic acid plays a crucial role in the creation of hydrogels and scaffolds for tissue engineering. Through its capacity to cross-link peptide chains, it imparts structural integrity and functional attributes to biomaterials, fostering the development of bioactive materials conducive to cell growth and tissue regeneration.

Protein Interaction Studies: Leveraging Fmoc-GGFG-Glycolic acid, researchers delve into protein-peptide interactions and the formulation of peptidomimetics. By integrating this conjugate into peptides, scientists investigate binding affinities and action mechanisms of peptides with their target proteins, essential for designing peptide-based inhibitors and therapeutics aimed at precise molecular interventions.

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

Related Products

Contact our experts today for pricing and comprehensive details on our ADC offerings.

You May Also Be Interested In

From cytotoxin synthesis to linker design, discover our specialized services that complement your ADC projects.

ADC Linker Development Enzyme Cleavable Linker Cathepsin B Cleavable Linker/Peptide Linker Phosphatase Cleavable Linker β-Glucuronide Linker β-Galactosidase Cleavable Linker Sulfatase Cleavable Linker Chemically Cleavable Linker Non-Cleavable Linker Services Acid Cleavable Linker/Hydrazone Linker

Unlock Deeper ADC Insights

Learn more about payload design, linker strategies, and integrated CDMO support through our curated ADC content.

Linkers - A Crucial Factor in Antibody–Drug Conjugates In-Depth Review of ADC Linkers: Types, Mechanisms, and Research Progress New Structural Insights Solve Instability Issues of Maleimide Linkers in ADCs PEG Linkers in Antibody-Drug Conjugates Peptide Linkers in Antibody-Drug Conjugates Disulfide Linkers in Antibody-Drug Conjugates Biotinylation Reagents in Antibody-Drug Conjugates Maleimide Linkers in Antibody-Drug Conjugates Current ADC Linker Chemistry SPDB Linkers in Antibody-Drug Conjugates

Explore More ADC Products

Find exactly what your project needs from our expanded range of ADCs, offering flexible options to fit your timelines and goals.

ADC Cytotoxin

Powerful Targeted Cancer Solutions

ADC  Cytotoxin with Linker

Enhanced Stability And Efficacy

ADC Linker

Precise Conjugation For Success

Antibody-Drug  Conjugates (ADCs)

Maximized Therapeutic Performance

Auristatins

Next-Level Tubulin Inhibition

Calicheamicins

High-Impact DNA Targeting

Camptothecins

Advanced Topoisomerase Inhibition

Daunorubicins / Doxorubicins

Trusted Anthracycline Payloads

Duocarmycins

Potent DNA Alkylation Agents

Maytansinoids

Superior Microtubule Disruption

Pyrrolobenzodiazepines

Ultra-Potent DNA Crosslinkers

Traditional Cytotoxic Agents

Proven Chemotherapy Solutions

Cleavable Linker

Precise Intracellular Drug Release

Non-Cleavable Linker

Exceptional Long-Term Stability

Historical Records: Fmoc-PEG3-Ala-Ala-Asn(Trt)-PAB | Ala-Ala-Asn-PAB | Fmoc-PEG4-Ala-Ala-Asn-PAB | Azido-PEG5-Ala-Ala-Asn-PAB | Fmoc-GGFG-Glycolic acid
Send Inquiry
Verification code
Inquiry Basket